DO
CORT icon

denkapparat Operations’s Corcept Therapeutics CORT Stock Holding History

denkapparat Operations’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-5,068
Closed -$579K – 252
2025
Q1 		$579K Sell
5,068
-928
-15% -$56.5K 0.61% 51
2024
Q4 		$302K Buy
+5,996
New +$314K 0.45% 92

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

denkapparat Operations's CORT Position: Q2 2025 in Review

denkapparat Operations sold out of Corcept Therapeutics (CORT) in Q2 2025, closing a stake of 5,068 shares — an estimated $579K sold.

denkapparat Operations first reported a position in CORT in Q4 2024 and held it in 2 quarters. The position peaked at $579K in Q1 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2025.

  • denkapparat Operations reported no remaining Corcept Therapeutics position as of Q2 2025 after selling out during the quarter.
  • denkapparat Operations sold 5,068 Corcept Therapeutics shares in Q2 2025, an estimated $579K.
  • denkapparat Operations first reported a position in Corcept Therapeutics in Q4 2024 and held it in 2 quarters.
  • denkapparat Operations's Corcept Therapeutics position peaked at $579K in Q1 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2025.

Based on denkapparat Operations's 13F filing for Q2 2025, filed 8 Aug 2025.